Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina

Molecular Vision

Volumn 16, Issue , 2010, Pages 2317-2327

  Gesslein, Bodil ^a   Håkansson, Gisela ^a   Gustafsson, Lotta ^a   Ekström, Per ^a   Malmsjö, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; FLUORESCEIN; MESSENGER RNA; SMOOTH MUSCLE ACTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; IMMUNOASSAY; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTRACELLULAR SIGNALING; INTRAOCULAR PRESSURE; MALE; MUELLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINA ANGIOGRAPHY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA INJURY; RETINA INNER PLEXIFORM LAYER; RETINA ISCHEMIA; SHAM PROCEDURE; SWINE; VITREOUS BODY;

ANIMALS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; FUNDUS OCULI; GENE EXPRESSION REGULATION; IMAGING, THREE-DIMENSIONAL; INTRAOCULAR PRESSURE; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REPERFUSION INJURY; RETINA; RETINAL NEURONS; RETINAL VESSELS; RNA, MESSENGER; SUS SCROFA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149476823     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23:91-147.
2. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66:232-45.
3. Lin CH, Chen M, Sun MC. Circulating apoptotic factors in patients with acute cerebral infarction. Clin Biochem 2010; 43:761-3.
4. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25:1481-8.
5. Schulz R, Aker S, Belosjorow S, Heusch G. TNFalpha in ischemia-reperfusion injury and heart failure. Basic Res Cardiol 2004; 99:8-11.
6. Heba G, Krzeminski T, Porc M, Grzyb J, Ratajska A, Dembinska-Kiec A. The time course of tumor necrosis factoralpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. J Vasc Res 2001; 38:288-300.
7. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22:RC216.
8. Gustavsson C, Agardh CD, Hagert P, Agardh E. Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina 2008; 28:645-52.
9. Kramer M, Dadon S, Hasanreisoglu M, Monselise Y, Avraham BR, Feldman A, Eldar I, Weinberger D, Goldenberg-Cohen N. Proinflammatory cytokines in a mouse model of central retinal artery occlusion. Mol Vis 2009; 15:885-94.
10. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001; 42:1787-94.
11. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C, Eaton E, Luedemann C, Ma H, Asahara T, Zak V, Mehta S, Burg A, Thorne T, Kishore R, Losordo DW. Tumor necrosis factor-alpha receptor p75 is required in ischemiainduced neovascularization. Circulation 2007; 115:752-62.
12. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997; 17:4015-23.
13. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996; 80:168-73.
14. Molnár L, Berki T, Hussain A, Nemeth P, Losonczy H. Detection of TNFalpha expression in the bone marrow and determination of TNFalpha production of peripheral blood mononuclear cells in myelodysplastic syndrome. Pathol Oncol Res 2000; 6:18-23.
15. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10:45-65.
16. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004; 8:445-54.
17. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by Nmethyl- D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinasedependent NF-kappa B pathway. J Biol Chem 2004; 279:32869-81.
18. Gesslein B, Gustafsson L, Wackenfors A, Ghosh F, Malmsjo M. Protein kinase C in porcine retinal arteries and neuroretina following retinal ischemia-reperfusion. Mol Vis 2009; 15:737-46.
19. Gesslein B, Håkansson G, Carpio R, Gustafsson L, Perez M, Malmsjo M. Mitogen-activated protein kinases in the porcine retinal arteries and neuroretina following retinal ischemiareperfusion. Mol Vis 2010; 16:392-407.
20. Moren H, Gesslein B, Andreasson S, Malmsjo M. Multifocal electroretinogram for functional evaluation of retinal injury following ischemia-reperfusion in pigs. Graefes Arch Clin Exp Ophthalmol 2010; 248:627-34.
21. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In, Krawetz S, editor. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press; 2000. p. 365-86.
22. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-93.
23. M. D. Abràmoff PJM. S. J. Ram. Image Processing with ImageJ. Biophotonics International 2004; 11:36-42.
24. Johansson UE, Eftekhari S, Warfvinge K. A battery of cell- and structure-specific markers for the adult porcine retina. J Histochem Cytochem 2010; 58:377-89.
25. la Cour M, Kiilgaard JF, Eysteinsson T, Wiencke AK, Bang K, Dollerup J, Jensen PK, Stefánsson E. Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. Br J Ophthalmol 2000; 84:1045-9.
26. Joshi S, Wang M, Nishanian EV, Emerson RG. Electrocerebral silence by intracarotid anesthetics does not affect early hyperemia after transient cerebral ischemia in rabbits. Anesth Analg 2004; 98:1454-9.
27. Roth S, Pietrzyk Z. Blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 1994; 35:3209-17.
28. Adamiec-Mroczek J, Oficjalska-Mlynczak J, Misiuk-Hojlo M. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples. Cytokine 2010; 49:269-74.
29. Gustavsson C, Agardh E, Bengtsson B, Agardh CD. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complications 2008; 22:309-16.
30. Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20:8693-700.
31. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002; 296:1634-5.
32. Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, Meldgaard M, Finsen B. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 2007; 144:934-49.
33. Sairanen TR, Lindsberg PJ, Brenner M, Carpen O, Siren A. Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 2001; 186:87-99.
34. Sriram K, O'Callaghan JP. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2007; 2:140-53.
35. Yin L, Ohtaki H, Nakamachi T, Kudo Y, Makino R, Shioda S. Delayed expressed TNFR1 co-localize with ICAM-1 in astrocyte in mice brain after transient focal ischemia. Neurosci Lett 2004; 370:30-5.
36. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117:244-79.
37. Licastro F, Chiappelli M, Ianni M, Porcellini E. Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules. Int J Immunopathol Pharmacol 2009; 22:567-72.
38. Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N. Adverse events after intravitreal infliximab (Remicade). Retina 2010; 30:71-80.
39. Theodossiadis PG, Liarakos VS, Sfikakis PP, Vergados IA, Theodossiadis GP. Intravitreal administration of the antitumor necrosis factor agent infliximab for neovascular agerelated macular degeneration. Am J Ophthalmol 2009; 147:825-30.